ABVC BioPharma Inc
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
(0.0% 1d) (-1.0% 1m) (57.2% 1y) (0.0% 2d) (0.0% 3d) (2.0% 7d) (84.45% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 14,362,173
https://abvcpharma.com
Sec Filling | Patents | 34 employees
ABVC BioPharma is a clinical-stage biopharmaceutical company focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research institutions (such as Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center). The company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development.
adhd
add to watch list Paper trade email alert is off
Press-releases
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: -1.96%
H: 0.0%
C: 0.0%
life biopharma acquired
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: 2.68%
H: 3.48%
C: -11.3%
treatment biopharma royalties global for agreement
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: 5.74%
H: 1.55%
C: -11.63%
biopharma royalties global for
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: 33.81%
H: 3.2%
C: -8.9%
vitargus biopharma royalties global deal
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
Published: 2024-03-21 (Crawled : 12:30) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: -0.54%
H: 3.33%
C: -1.32%
million biopharma
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
Published: 2024-03-19 (Crawled : 12:30) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: -1.72%
H: 0.0%
C: 0.0%
ceo asia
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
Published: 2024-03-14 (Crawled : 13:30) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: -0.81%
H: 0.0%
C: 0.0%
first business year update biopharma
ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Published: 2024-02-27 (Crawled : 13:30) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: 0.82%
H: 0.0%
C: 0.0%
cancer market
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
Published: 2024-02-15 (Crawled : 13:30) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: -0.4%
H: 0.0%
C: 0.0%
license biopharma royalties agreement
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
Published: 2024-02-12 (Crawled : 13:30) - globenewswire.com
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
|
| O: -0.76%
H: 3.05%
C: 2.29%
treatment biopharma
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
CTRN P 52495 | $22.25 0.14% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
RELL P 2500 | $10.335 2.13% 2.08% 98K
|
Electronic Technology
|
20:01
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
HNVR | $16.76 2.51% 2.45% 3.5K
|
|
16:30
VUZI P 34500 | $1.315 -2.59% -2.66% 690K
|
Electronic Technology
|
16:00
TPL P 3 | $587.81 0.34% -0.39% 41K
|
Miscellaneous
|
15:00
ETST P 79000 | $0.065 -67.14% 110K
|
Manufacturing
|
11:30
MCFT P 26039 | $21.06 -2.05% -2.09% 130K
|
Consumer Durables
|
00:00
YORW P 29 | $35.625 0.58% 0.58% 56K
|
Utilities
|
19:01
BANF P 256 | $92.29 1.11% 1.09% 92K
|
Finance
|
15:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10